Oxcia AB (publ)

Oxcia AB is a pioneer in oxidative DNA damage and DNA Damage Response (DDR – the body’s way of repairing the damage that occurs to DNA). The two most advanced projects emanating from the O2-DDR technology platform are OXC-101 for cancer and OXC-201 for pulmonary fibrosis. The portfolio also includes... Read more